Enrico Di Oto

Enrico Di Oto is the CEO of OACP IE LTD, a company operating in the field of Medical Biotechnology/Diagnostics. OACP specializes in designing, developing, and selling innovative rapid diagnostics for cancer and infectious diseases based on molecular biology techniques.

Enrico’s educational background and skills in biology, business management, planning, and operations have been instrumental in his successful career. He has led several research projects and collaborated with small businesses, contributing to the advancement of the field.

Among his professional accomplishments, Enrico is proud to have been awarded Best Biotech at the ITC 2022, recognizing his outstanding contributions to the industry.

Throughout his career, Enrico has witnessed the evolution of the industry. The market has seen the emergence of numerous small players, while larger companies are relocating their resources. These changes have brought new challenges, including international regulations that lack homogeneity across different continents and increased competition from both established and emerging Asian companies.

Looking ahead, Enrico envisions a significant shift in the industry from a business-to-business (B2B) model to a business-to-consumer (B2C) model in the next 5-10 years.

Enrico is particularly excited about the technologies developed by OACP, which he believes will drive innovation in the industry.

For those starting in the industry, Enrico advises studying the market extensively, understanding its trends, and adopting a medium-to-long-term mindset. This approach allows individuals to make informed decisions and navigate the challenges of the industry effectively.

In handling setbacks and challenges, Enrico emphasizes the advantage of OACP’s lean company structure, which enables the rapid adaptation to industry challenges and setbacks.

Outside of his professional life, Enrico has a passion for history, gaming, and sports. These interests provide him with a well-rounded perspective and contribute to his personal growth and relaxation.

Enrico draws inspiration from prominent figures from the past, such as Sir Winston Churchill, who exemplify resilience and leadership.

Through his role at OACP IE LTD and his contributions to the field of Medical Biotechnology/Diagnostics, Enrico Di Oto demonstrates a dedication to driving innovation, overcoming industry challenges, and making a positive impact on global healthcare.